| Literature DB >> 24841151 |
Amira Barketi-Klai1, Marc Monot2, Sandra Hoys1, Sylvie Lambert-Bordes1, Sarah A Kuehne3, Nigel Minton3, Anne Collignon2, Bruno Dupuy2, Imad Kansau1.
Abstract
Clostridium difficile is the main agent responsible for hospital acquired antibiotic associated diarrhoea. In recent years, epidemic strains have emerged causing more severe infections. Whilst C. difficile has two major virulence factors, toxins TcdA and TcdB, it is generally accepted that other virulence components of the bacterium contribute to disease. Previously, it has been suggested that flagella expression from pathogenic bacteria might be implicated in virulence. In a recent study, we observed an increased mortality in a gnotobiotic mouse model when animals were colonized with an isogenic fliC mutant constructed in the PCR-ribotype 027 (B1/NAP1) strain R20291, while animals survived when colonized by the parental strain or after colonization by other high-toxin-producing C. difficile strains. To understand the reasons for this increased virulence, we compared the global gene expression profiles between the fliC-R20291 mutant and its parental strain using an in vitro and in vivo transcriptomic approach. The latter made use of the gnotobiotic mouse model. Interestingly, in the fliC mutant, we observed considerable up-regulation of genes involved in mobility, membrane transport systems (PTS, ABC transporters), carbon metabolism, known virulence factors and sporulation. A smaller but significant up-regulation of genes involved in cell growth, fermentation, metabolism, stress and antibiotic resistance was also apparent. All of these genes may be associated with the increased virulence of the fliC-R20921 mutant. We confirmed that the fliC mutation is solely responsible for the observed changes in gene expression in the mutant strain since expression profiles were restored to that of the wild-type strain in the fliC-complemented strain. Thus, the absence of FliC is directly or indirectly involved in the high mortality observed in the fliC mutant infected animals. Therefore, we provide the first evidence that when the major structural component of the flagellum is neutralized, deregulation of gene expression can occur during infection.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24841151 PMCID: PMC4026244 DOI: 10.1371/journal.pone.0096876
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Functional clusters of in vivo differentially expressed genes.
Differentially expressed genes in the fliC mutant compared to wild-type R20291 from caeca of 14 h post-infection mice were classified in functional groups according to their involvement in the biological process categories. (A) The number of analyzed genes is represented in green bars and the number of significantly differentially expressed genes is shown in black bars. Percentages of differentially regulated genes are indicated at right. (B) The numbers of up- and down-regulated genes for each cluster are indicated in green and black bars, respectively.
Flagellar genes differentially expressed in vivo in the fliC mutant.
| Gene ID | Gene ortholog | Name | Description | Microarray fold change |
| CDR0227 | CD630_02260 | Putative lytic transglycosylase | 2.03 | |
| CDR0230 | CD630_02290 |
| Negative regulator of flagellin synthesis (anti-sigma-d factor) | 0.20 |
| CDR0231 | CD630_02300 | Putative flagellar biosynthesis protein | 3.30 | |
| CDR0232 | CD630_02310 |
| Flagellar hook-associated protein FlgK (or HAP1) | 0.40 |
| CDR0234 | CD630_02330 |
| Flagella assembly factor FliW | 2.03 |
| CDR0235 | CD630_02340 |
| Carbon storage regulator homolog CsrA | 4.36 |
| CDR0236 | CD630_02350 |
| Flagellar protein FliS | 3.99 |
| CDR0237 | CD630_02360 |
| Flagellar protein FliS2 | 2.17 |
| CDR0238 | CD630_02370 |
| Flagellar cap protein | 5.05 |
| CDR0239 | CD196_0252 | Conserved hypothetical protein | 4.99 | |
| CDR0240 | CD630_02390 |
| Flagellin subunit FliC | 0.11 |
| CDR0248 | CD630_02450** |
| Flagellar basal-body rod protein FlgB | 0.34 |
| CDR0249 | CD630_02460** |
| Flagellar basal-body rod protein FlgC | 0.31 |
| CDR0250 | CD630_02470** |
| Flagellar hook-basal body complex protein FliE | 0.25 |
| CDR0251 | CD630_02480** |
| Flagellar M-ring protein FliF | 0.28 |
| CDR0252 | CD630_02490** |
| Flagellar motor switch protein FliG | 0.18 |
| CDR0253 | CD630_02500** |
| Flagellar assembly protein FliH | 0.35 |
| CDR0254 | CD630_02510** |
| Flagellum-specific ATP synthase subunit beta FliI | 0.39 |
| CDR0255 | CD630_02520** |
| Flagellar protein FliJ | 0.41 |
| CDR0256 | CD630_02530** |
| Flagellar hook-length control protein FliK | 0.30 |
| CDR0257 | CD630_02540** |
| Basal-body rod modification protein FlgD | 0.29 |
| CDR0258 | CD630_02550** |
| Flagellar hook protein FlgE (distal rod protein) | 0.32 |
| CDR0259 | CD630_02551** |
| Flagellar protein FlbD | 0.24 |
| CDR0260 | CD630_02560** |
| Flagellar motor rotation protein MotA (chemotaxis protein) | 0.19 |
| CDR0261 | CD630_02570** |
| Flagellar motor rotation protein MotB (chemotaxis protein) | 0.36 |
| CDR0262 | CD630_02580** |
| Flagellar basal body-associated protein FliL | 0.51 |
| CDR0264 | CD630_02600** |
| Flagellar biosynthesis protein FliP | 0.40 |
| CDR0267 | CD630_02630** |
| Flagellar biosynthesis protein FlhA | 0.41 |
| CDR0268 | CD630_02640** |
| Flagellar biosynthesis regulator FlhF (flagella-associated GTP-binding protein) | 0.43 |
| CDR0269 | CD630_02650** |
| Flagellar number regulator FlhG | 0.47 |
| CDR0270 | CD630_02660** |
| RNA polymerase sigma 28 factor for flagellar operon | 0.42 |
| CDR0271 | CD630_02670** | Putative flagellar protein | 0.31 | |
| CDR0274 | CD630_02700** |
| Flagellar motor switch phosphatase FliM | 0.45 |
| CDR0276 | CD630_02720** | Conserved hypothetical protein | 0.47 |
*From F1 region (late-stage flagellar genes) and **F3 region (early-stage flagellar genes) of the flagellar operon from C. difficile 630 [39].
Membrane transport genes highly differentially expressed in vivo in the fliC mutant compared to strain R20291.
| Gene ID | Gene ortholog | Name | Description | Microarray fold change |
|
| ||||
| CDR0783 | CD630_08530 |
| ABC-type transport system, oligopeptide-family permease | 0.07 |
| CDR0784 | CD630_08540 |
| ABC-type transport system, oligopeptide-family permease | 0.08 |
| CDR0785 | CD630_08550 |
| ABC-type transport system, oligopeptide-family extracellular solute-binding protein | 0.06 |
| CDR0786 | CD630_08560 |
| ABC-type transport system, ATP-binding component | 0.10 |
| CDR0787 | CD196_0806 |
| Oligopeptide ABC transporter, ATP-binding protein | 0.08 |
| CDR0551 | CD196_0569 | ABC transporter, ATP-binding/permease protein | 3.73 | |
| CDR2981 | CD196_2934 | Spermidine/putrescine ABC transporter ATP-binding subunit | 3.39 | |
| CDR2983 | CD196_2936 | Putative ABC-type transport system, periplasmic component-like protein precursor | 2.80 | |
|
| ||||
| CDR2927 | CD630_30880 | Putative cellobiose-phosphate degrading protein | 51.25 | |
| CDR2928 | CD630_30890 | PTS system, IIABC component | 32.82 | |
| CDR3136 | CD630_32750 | Putative phosphosugar isomerase | 10.06 | |
| CDR3137 | CD630_32760 | PTS system, mannose/fructose/sorbose IID component | 4.44 | |
| CDR3138 | CD630_32770 | PTS system, mannose/fructose/sorbose IIC component | 11.76 | |
| CDR3139 | CD630_32780 | PTS system, mannose/fructose/sorbose IIA component | 10.83 | |
| CDR3140 | CD630_32790 | PTS system, mannose/fructose/sorbose IIB component | 7.75 | |
| CDR2862 | CD630_30270 | PTS system, glucose-specific IIA component | 0.07 | |
| CDR2863 | CD630_30280 | Putative phosphosugar isomerase | 0.06 | |
| CDR2864 | CD630_30290 |
| Bifunctional protein: cystathionine beta-lyase/repressor | 0.05 |
| CDR2865 | CD630_30300 |
| PTS system, glucose-like IIBC component | 0.04 |
| CDR2866 | CD630_30310 | Transcription antiterminator, PTS operon regulator | 0.37 | |
Sporulation genes highly differentially expressed in vivo in the fliC mutant compared to strain R20291.
| Gene ID | Gene ortholog | Name | Description | Microarray fold change |
| CDR0212 | CD630_02130 | Putative spore coat protein | 6.88 | |
| CDR0213 | CD630_02140 | Conserved hypothetical protein | 8.22 | |
| CDR0337 | CD196_0351 | Fragment of putative exosporium glycoprotein | 3.22 | |
| CDR0522 | CD630_05970 |
| Spore-coat protein CotF | 2.58 |
| CDR0714 | CD630_07830 | Putative stage IV sporulation protein | 4.08 | |
| CDR1476 | CD630_15790 | Two-component sensor histidine kinase, sporulation associated | 2.46 | |
| CDR1511 | CD630_16130 |
| Spore outer coat layer protein CotA | 2.88 |
| CDR2289 | CD630_23990 | Conserved hypothetical protein | 2.93 | |
| CDR2291 | CD630_24010 |
| Spore-coat protein CotD; manganese catalase | 4.18 |
| CDR2802 | CD630_29670 |
| Dipicolinate synthase subunit B | 3.40 |
| CDR3090 | CD630_32300 |
| Putative exosporium glycoprotein | 3.32 |
| CDR3193 | CD630_33490 |
| Putative exosporium glycoprotein | 2.82 |
| CDR3406 | CD630_35690 | Sporulation_specific protease | 2.98 |
Figure 2Ability of sporulation of the fliC mutant compared to wild-type R20291 in vivo and in vitro.
(A) Groups of 6 axenic mice were infected by oral gavage route with 1×108 C. difficile CFU. The C. difficile faecal vegetative cells and spores were measured by determining the concentration of CFU in faeces at 14 h post-infection by homogenising and plating on appropriated agar medium after heat shock (for spores) or not (Materials and Methods). Data represent the ratio of spores per vegetative cells. (B) Cultures in BHIS broth in anaerobic conditions were prepared from 2 successive subcultures as indicated in Materials and Methods. After heat shock, spores were quantified (CFU/ml) by performing serial dilutions and spread plating on BHIS agar supplemented with 0.1% bile salt taurocholate to induce germination. Data represent the ratio of spores per total cells. The presented values are the mean of 3 different cultures. Statistically significant difference is indicated by * for p<0,05.
Known and putative virulence factor genes differentially expressed in vivo in the fliC mutant compared to strain R20291.
| Gene ID | Gene ortholog | Name | Description | Fold change (microarray) | Fold change (qRT-PCR) |
| CDR0584 | CD630_06630 |
| Toxin TcdA | 1 | 0.64 |
| CDR0582 | CD630_06600 |
| Toxin TcdB | 1 | 0.59 |
| CDR0585 | CD630_06640 |
| Negative regulator of toxin gene expression | 0.48 | 0.38 |
| CDR0581 | CD630_06590 |
| Alternative RNA polymerase sigma factors | 1 | ND |
| CDR0583 | CD630_06610 |
| Holin-like pore-forming protein | 1 | ND |
| CDR2491 | CD630_26040 |
| Fragment of ADP-ribosyltransferase CdtAB | 1 | 2.49 |
| CDR2492 | CD630_26050 |
| Fragment of ADP-ribosyltransferase CdtAB | 2.36 | 2.60 |
| CDR2479 | CD630_25920 |
| Fibronectin-binding protein A | 1 | 0.03 |
| CDR0195 | CD630_01940 |
| 60 kDa chaperonin (Protein Cpn60) (GroEL protein) | 1 | 0.36 |
| CDR2676 | CD630_27870 |
| Cell surface protein Cwp84 | 1 | 0.41 |
| CDR0224 | CD196_0237 | Glucose-1-phosphate thymidylyltransferase | 4.82 | 12.66 | |
| CDR2930 | CD630_30910 |
| Trehalose-6-phosphate hydrolase | 24.38 | 177.63 |
| CDR0152 | CD630_01530 |
| 4-hydroxyphenylacetate decarboxylase, catalytic subunit (p-cresol production) | 1 | 1.67 |
| CDR0154 | CD630_01550 |
| 4-hydroxyphenylacetate decarboxylase, activating subunit (p-cresol production) | 3.11 | 1.72 |
| CDR0598 | CD630_06750 |
| CsfT sigma factor (ECF sigma factors family) | 5.02 | 3.37 |
| CDR2092 | CD196_2049 | Lipoprotein | 2.31 | ND | |
| CDR0440 | CD196_0454 | Hemagglutinin/adhesin | 0.11 | ND |
ND: non determined.